 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0047134	protein-disulfide reductase activity	1	9.961664e-5	3.673862e-1	3.673862e-1	1.003848e+4	9.961664e-5	1	9.961664e-5	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	TXNDC17
GO Molecular Function	GO:0008526	phosphatidylinositol transporter activity	2	2.791641e-4	1.000000e+0	5.147786e-1	3.582122e+3	2.791641e-4	1	2.791641e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	ACKR6
GO Molecular Function	GO:0016668	oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor	3	4.417175e-4	1.000000e+0	5.430180e-1	2.263890e+3	4.417175e-4	1	4.417175e-4	1.000000e+0	3	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	TXNDC17
GO Molecular Function	GO:0004601	peroxidase activity	4	2.725406e-3	1.000000e+0	1.000000e+0	3.669178e+2	2.725406e-3	1	2.725406e-3	1.000000e+0	6	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	TXNDC17
GO Molecular Function	GO:0016209	antioxidant activity	5	3.982005e-3	1.000000e+0	1.000000e+0	2.511297e+2	3.982005e-3	1	3.982005e-3	1.000000e+0	8	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	TXNDC17
GO Molecular Function	GO:0005548	phospholipid transporter activity	6	4.273616e-3	1.000000e+0	1.000000e+0	2.339939e+2	4.273616e-3	1	4.273616e-3	1.000000e+0	4	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	ACKR6
GO Molecular Function	GO:0030971	receptor tyrosine kinase binding	7	5.309526e-3	1.000000e+0	1.000000e+0	1.883407e+2	5.309526e-3	1	5.309526e-3	1.000000e+0	5	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	ACKR6
GO Molecular Function	GO:0009055	electron carrier activity	8	5.710295e-3	1.000000e+0	1.000000e+0	1.751223e+2	5.710295e-3	1	5.710295e-3	1.000000e+0	10	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	TXNDC17
GO Molecular Function	GO:0016651	oxidoreductase activity, acting on NAD(P)H	9	5.719761e-3	1.000000e+0	1.000000e+0	1.748325e+2	5.719761e-3	1	5.719761e-3	1.000000e+0	11	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	TXNDC17
GO Molecular Function	GO:0016667	oxidoreductase activity, acting on a sulfur group of donors	10	5.917079e-3	1.000000e+0	1.000000e+0	1.690023e+2	5.917079e-3	1	5.917079e-3	1.000000e+0	7	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	TXNDC17
GO Molecular Function	GO:0005319	lipid transporter activity	11	6.813310e-3	1.000000e+0	1.000000e+0	1.467715e+2	6.813310e-3	1	6.813310e-3	1.000000e+0	9	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	ACKR6
GO Molecular Function	GO:0016491	oxidoreductase activity	12	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	13	7.769532e-2	1.000000e+0	1.000000e+0	1.261608e+1	7.926390e-2	1	715	5.000000e-1	1.398601e-3	unnamed	TXNDC17
GO Molecular Function	GO:0008289	lipid binding	13	8.303762e-2	1.000000e+0	1.000000e+0	1.204273e+1	8.303762e-2	1	8.303762e-2	1.000000e+0	14	8.194912e-2	1.000000e+0	1.000000e+0	1.194768e+1	8.369824e-2	1	755	5.000000e-1	1.324503e-3	unnamed	ACKR6
GO Molecular Function	GO:0005509	calcium ion binding	14	8.363577e-2	1.000000e+0	1.000000e+0	1.195661e+1	8.363577e-2	1	8.363577e-2	1.000000e+0	12	7.396518e-2	1.000000e+0	1.000000e+0	1.326544e+1	7.538385e-2	1	680	5.000000e-1	1.470588e-3	unnamed	ACKR6
GO Molecular Function	GO:0022892	substrate-specific transporter activity	15	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	15	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	ACKR6
GO Molecular Function	GO:0005215	transporter activity	16	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	16	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	ACKR6
GO Molecular Function	GO:0005102	receptor binding	17	1.214505e-1	1.000000e+0	1.000000e+0	8.233804e+0	1.214505e-1	1	1.214505e-1	1.000000e+0	17	1.292303e-1	1.000000e+0	1.000000e+0	7.479685e+0	1.336955e-1	1	1206	5.000000e-1	8.291874e-4	unnamed	ACKR6
GO Molecular Function	GO:0046872	metal ion binding	18	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	19	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	ACKR6
GO Molecular Function	GO:0043169	cation binding	19	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	20	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	ACKR6
GO Molecular Function	GO:0003824	catalytic activity	20	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	22	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	TXNDC17
GO Molecular Function	GO:0043167	ion binding	21	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	23	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	ACKR6
GO Molecular Function	GO:0005515	protein binding	22	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	18	1.964729e-1	1.000000e+0	1.000000e+0	2.255971e+0	8.865362e-1	2	7997	1.000000e+0	2.500938e-4	unnamed	ACKR6,TXNDC17
GO Molecular Function	GO:0005488	binding	23	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	21	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	ACKR6,TXNDC17
GO Biological Process	GO:0033209	tumor necrosis factor-mediated signaling pathway	1	2.355197e-3	1.000000e+0	1.000000e+0	4.245929e+2	2.355197e-3	1	2.355197e-3	1.000000e+0	1	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	TXNDC17
GO Biological Process	GO:0071356	cellular response to tumor necrosis factor	2	7.339100e-3	1.000000e+0	1.000000e+0	1.362565e+2	7.339100e-3	1	7.339100e-3	1.000000e+0	2	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	TXNDC17
GO Biological Process	GO:0034612	response to tumor necrosis factor	3	9.003188e-3	1.000000e+0	1.000000e+0	1.110718e+2	9.003188e-3	1	9.003188e-3	1.000000e+0	3	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	TXNDC17
GO Biological Process	GO:0046488	phosphatidylinositol metabolic process	4	1.046233e-2	1.000000e+0	1.000000e+0	9.558100e+1	1.046233e-2	1	1.046233e-2	1.000000e+0	4	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	ACKR6
GO Biological Process	GO:0006650	glycerophospholipid metabolic process	5	1.897883e-2	1.000000e+0	1.000000e+0	5.269028e+1	1.897883e-2	1	1.897883e-2	1.000000e+0	5	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	ACKR6
GO Biological Process	GO:0006644	phospholipid metabolic process	6	2.293343e-2	1.000000e+0	1.000000e+0	4.360446e+1	2.293343e-2	1	2.293343e-2	1.000000e+0	6	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	ACKR6
GO Biological Process	GO:0019221	cytokine-mediated signaling pathway	7	2.332991e-2	1.000000e+0	1.000000e+0	4.286343e+1	2.332991e-2	1	2.332991e-2	1.000000e+0	8	3.527000e-2	1.000000e+0	1.000000e+0	2.810125e+1	3.558561e-2	1	321	5.000000e-1	3.115265e-3	unnamed	TXNDC17
GO Biological Process	GO:0046486	glycerolipid metabolic process	8	2.379859e-2	1.000000e+0	1.000000e+0	4.201929e+1	2.379859e-2	1	2.379859e-2	1.000000e+0	7	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	ACKR6
GO Biological Process	GO:0071345	cellular response to cytokine stimulus	9	3.467208e-2	1.000000e+0	1.000000e+0	2.884165e+1	3.467208e-2	1	3.467208e-2	1.000000e+0	9	4.764342e-2	1.000000e+0	1.000000e+0	2.073678e+1	4.822349e-2	1	435	5.000000e-1	2.298851e-3	unnamed	TXNDC17
GO Biological Process	GO:0034097	response to cytokine stimulus	10	4.481356e-2	1.000000e+0	1.000000e+0	2.231468e+1	4.481356e-2	1	4.481356e-2	1.000000e+0	10	5.735550e-2	1.000000e+0	1.000000e+0	1.718190e+1	5.820076e-2	1	525	5.000000e-1	1.904762e-3	unnamed	TXNDC17
GO Biological Process	GO:0044255	cellular lipid metabolic process	11	7.113785e-2	1.000000e+0	1.000000e+0	1.405721e+1	7.113785e-2	1	7.113785e-2	1.000000e+0	11	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	ACKR6
GO Biological Process	GO:0019637	organophosphate metabolic process	12	8.707730e-2	1.000000e+0	1.000000e+0	1.148405e+1	8.707730e-2	1	8.707730e-2	1.000000e+0	12	1.118684e-1	1.000000e+0	1.000000e+0	8.681906e+0	1.151821e-1	1	1039	5.000000e-1	9.624639e-4	unnamed	ACKR6
GO Biological Process	GO:0006629	lipid metabolic process	13	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	13	1.144784e-1	1.000000e+0	1.000000e+0	8.477914e+0	1.179536e-1	1	1064	5.000000e-1	9.398496e-4	unnamed	ACKR6
GO Biological Process	GO:0071310	cellular response to organic substance	14	1.544577e-1	1.000000e+0	1.000000e+0	6.474265e+0	1.544577e-1	1	1.544577e-1	1.000000e+0	14	1.591759e-1	1.000000e+0	1.000000e+0	6.021696e+0	1.660662e-1	1	1498	5.000000e-1	6.675567e-4	unnamed	TXNDC17
GO Biological Process	GO:0070887	cellular response to chemical stimulus	15	1.826020e-1	1.000000e+0	1.000000e+0	5.476391e+0	1.826020e-1	1	1.826020e-1	1.000000e+0	15	1.959705e-1	1.000000e+0	1.000000e+0	4.839324e+0	2.066404e-1	1	1864	5.000000e-1	5.364807e-4	unnamed	TXNDC17
GO Biological Process	GO:0006796	phosphate-containing compound metabolic process	16	1.861159e-1	1.000000e+0	1.000000e+0	5.372996e+0	1.861159e-1	1	1.861159e-1	1.000000e+0	16	2.116001e-1	1.000000e+0	1.000000e+0	4.461177e+0	2.241561e-1	1	2022	5.000000e-1	4.945598e-4	unnamed	ACKR6
GO Biological Process	GO:0006793	phosphorus metabolic process	17	1.905359e-1	1.000000e+0	1.000000e+0	5.248354e+0	1.905359e-1	1	1.905359e-1	1.000000e+0	18	2.159254e-1	1.000000e+0	1.000000e+0	4.366167e+0	2.290339e-1	1	2066	5.000000e-1	4.840271e-4	unnamed	ACKR6
GO Biological Process	GO:0010033	response to organic substance	18	2.019131e-1	1.000000e+0	1.000000e+0	4.952626e+0	2.019131e-1	1	2.019131e-1	1.000000e+0	17	2.147469e-1	1.000000e+0	1.000000e+0	4.391675e+0	2.277036e-1	1	2054	5.000000e-1	4.868549e-4	unnamed	TXNDC17
GO Biological Process	GO:0044710	single-organism metabolic process	19	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	20	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	ACKR6
GO Biological Process	GO:0007166	cell surface receptor signaling pathway	20	2.539087e-1	1.000000e+0	1.000000e+0	3.938424e+0	2.539087e-1	1	2.539087e-1	1.000000e+0	19	2.743799e-1	1.000000e+0	1.000000e+0	3.374673e+0	2.963250e-1	1	2673	5.000000e-1	3.741115e-4	unnamed	TXNDC17
GO Biological Process	GO:0006810	transport	21	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	21	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	ACKR6
GO Biological Process	GO:0051234	establishment of localization	22	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	23	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	ACKR6
GO Biological Process	GO:0042221	response to chemical stimulus	23	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	22	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	TXNDC17
GO Biological Process	GO:0051179	localization	24	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	24	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	ACKR6
GO Biological Process	GO:0007165	signal transduction	25	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	25	4.201465e-1	1.000000e+0	1.000000e+0	2.096328e+0	4.770246e-1	1	4303	5.000000e-1	2.323960e-4	unnamed	TXNDC17
GO Biological Process	GO:0044700	single organism signaling	26	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	26	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	TXNDC17
GO Biological Process	GO:0007154	cell communication	27	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	27	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	TXNDC17
GO Biological Process	GO:0051716	cellular response to stimulus	28	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	28	5.039946e-1	1.000000e+0	1.000000e+0	1.690815e+0	5.914306e-1	1	5335	5.000000e-1	1.874414e-4	unnamed	TXNDC17
GO Biological Process	GO:0050896	response to stimulus	29	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	30	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	TXNDC17
GO Biological Process	GO:0044237	cellular metabolic process	30	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	31	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	ACKR6
GO Biological Process	GO:0044238	primary metabolic process	31	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	32	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	ACKR6
GO Biological Process	GO:0071704	organic substance metabolic process	32	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	33	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	ACKR6
GO Biological Process	GO:0008152	metabolic process	33	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	35	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	ACKR6
GO Biological Process	GO:0050794	regulation of cellular process	34	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	34	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	TXNDC17
GO Biological Process	GO:0050789	regulation of biological process	35	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	36	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	TXNDC17
GO Biological Process	GO:0065007	biological regulation	36	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	37	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	TXNDC17
GO Biological Process	GO:0044763	single-organism cellular process	37	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	38	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	TXNDC17
GO Biological Process	GO:0044699	single-organism process	38	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	39	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	TXNDC17
GO Biological Process	GO:0009987	cellular process	39	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	29	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	ACKR6,TXNDC17
GO Cellular Component	GO:0012505	endomembrane system	1	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	1	1.741537e-1	1.000000e+0	1.000000e+0	5.480255e+0	1.824733e-1	1	1646	5.000000e-1	6.075334e-4	unnamed	ACKR6
GO Cellular Component	GO:0005829	cytosol	2	2.084988e-1	1.000000e+0	1.000000e+0	4.796191e+0	2.084988e-1	1	2.084988e-1	1.000000e+0	2	2.663307e-1	1.000000e+0	1.000000e+0	3.485510e+0	2.869021e-1	1	2588	5.000000e-1	3.863988e-4	unnamed	TXNDC17
GO Cellular Component	GO:0016021	integral to membrane	3	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	3	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	ACKR6
GO Cellular Component	GO:0031224	intrinsic to membrane	4	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	5	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	ACKR6
GO Cellular Component	GO:0044444	cytoplasmic part	5	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	7	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	TXNDC17
GO Cellular Component	GO:0044425	membrane part	6	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	6	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	ACKR6
GO Cellular Component	GO:0016020	membrane	7	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	10	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	ACKR6
GO Cellular Component	GO:0005737	cytoplasm	8	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	11	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	TXNDC17
GO Cellular Component	GO:0044424	intracellular part	9	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	12	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	TXNDC17
GO Cellular Component	GO:0005622	intracellular	10	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	4	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	ACKR6,TXNDC17
GO Cellular Component	GO:0044464	cell part	11	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	8	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	ACKR6,TXNDC17
GO Cellular Component	GO:0005623	cell	12	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	9	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	ACKR6,TXNDC17
Human Phenotype	HP:0008008	Progressive central visual loss	1	1.564374e-4	9.614643e-1	9.614643e-1	6.392334e+3	1.564374e-4	1	1.564374e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	ACKR6
Human Phenotype	HP:0000603	Central scotoma	2	5.705162e-4	1.000000e+0	1.000000e+0	1.752799e+3	5.705162e-4	1	5.705162e-4	1.000000e+0	2	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	ACKR6
Human Phenotype	HP:0007663	Decreased central vision	3	9.150599e-4	1.000000e+0	1.000000e+0	1.092825e+3	9.150599e-4	1	9.150599e-4	1.000000e+0	3	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	ACKR6
Human Phenotype	HP:0000575	Scotoma	4	9.723214e-4	1.000000e+0	1.000000e+0	1.028467e+3	9.723214e-4	1	9.723214e-4	1.000000e+0	4	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	ACKR6
Human Phenotype	HP:0000529	Progressive visual loss	5	2.022007e-3	1.000000e+0	1.000000e+0	4.945582e+2	2.022007e-3	1	2.022007e-3	1.000000e+0	5	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	ACKR6
Human Phenotype	HP:0001123	Visual field defect	6	5.930192e-3	1.000000e+0	1.000000e+0	1.686286e+2	5.930192e-3	1	5.930192e-3	1.000000e+0	8	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	ACKR6
Human Phenotype	HP:0000572	Visual loss	7	6.223177e-3	1.000000e+0	1.000000e+0	1.606896e+2	6.223177e-3	1	6.223177e-3	1.000000e+0	7	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	ACKR6
Human Phenotype	HP:0000551	Abnormality of color vision	8	7.170605e-3	1.000000e+0	1.000000e+0	1.394583e+2	7.170605e-3	1	7.170605e-3	1.000000e+0	6	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	ACKR6
Human Phenotype	HP:0000662	Night blindness	9	9.351489e-3	1.000000e+0	1.000000e+0	1.069348e+2	9.351489e-3	1	9.351489e-3	1.000000e+0	9	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	ACKR6
Human Phenotype	HP:0000613	Photophobia	10	1.130566e-2	1.000000e+0	1.000000e+0	8.845131e+1	1.130566e-2	1	1.130566e-2	1.000000e+0	10	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	ACKR6
Human Phenotype	HP:0007703	Abnormal retinal pigmentation	11	1.943895e-2	1.000000e+0	1.000000e+0	5.144311e+1	1.943895e-2	1	1.943895e-2	1.000000e+0	11	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	ACKR6
Human Phenotype	HP:0008051	Abnormality of the retinal pigment epithelium	12	2.142508e-2	1.000000e+0	1.000000e+0	4.667427e+1	2.142508e-2	1	2.142508e-2	1.000000e+0	12	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	ACKR6
Human Phenotype	HP:0000479	Abnormality of the retina	13	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	13	4.829244e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	441	5.000000e-1	2.267574e-3	unnamed	ACKR6
Human Phenotype	HP:0000505	Visual impairment	14	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	14	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	ACKR6
Human Phenotype	HP:0000504	Abnormality of vision	15	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	15	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	ACKR6
Human Phenotype	HP:0001098	Abnormality of the fundus	16	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	17	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	ACKR6
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	17	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	18	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	ACKR6
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	18	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	16	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	ACKR6
Human Phenotype	HP:0012373	Abnormal eye physiology	19	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	19	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	ACKR6
Human Phenotype	HP:0012374	Abnormality of the globe	20	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	20	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	ACKR6
Human Phenotype	HP:0012372	Abnormal eye morphology	21	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	21	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	ACKR6
Human Phenotype	HP:0000006	Autosomal dominant inheritance	22	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	22	1.191667e-1	1.000000e+0	1.000000e+0	8.133904e+0	1.229422e-1	1	1109	5.000000e-1	9.017133e-4	unnamed	ACKR6
Human Phenotype	HP:0000478	Abnormality of the eye	23	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	23	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	ACKR6
Human Phenotype	HP:0011446	Abnormality of higher mental function	24	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	24	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	ACKR6
Human Phenotype	HP:0002011	Abnormality of the central nervous system	25	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	25	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	ACKR6
Human Phenotype	HP:0000707	Abnormality of the nervous system	26	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	26	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	ACKR6
Human Phenotype	HP:0000005	Mode of inheritance	27	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	27	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	ACKR6
Human Phenotype	HP:0000118	Phenotypic abnormality	28	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	28	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	ACKR6
Human Phenotype	HP:0000001	All	29	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	29	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	ACKR6
Disease Ontology	DOID:4241	malignant neoplasm of breast	1	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	1	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	ACKR6
Disease Ontology	DOID:3937	malignant neoplasm of thorax	2	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	2	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	ACKR6
Disease Ontology	DOID:5093	thoracic cancer	3	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	3	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	ACKR6
Disease Ontology	DOID:1612	mammary cancer	4	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	4	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	ACKR6
Disease Ontology	DOID:193	reproductive system cancer	5	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	5	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	ACKR6
Disease Ontology	DOID:462	cancer by anatomical entity	6	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	6	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	ACKR6
Disease Ontology	DOID:162	cancer	7	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	7	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	ACKR6
Disease Ontology	DOID:4	disease	8	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	8	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	ACKR6
MSigDB Perturbation	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	Down-regulated genes specific to esophageal adenocarcinoma (EAC) relative to normal tissue.	1	7.427959e-3	1.000000e+0	1.000000e+0	1.346265e+2	7.427959e-3	1	7.427959e-3	1.000000e+0	2	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	TXNDC17
MSigDB Perturbation	GYORFFY_DOXORUBICIN_RESISTANCE	Genes associated with resistance to doxorubicin [PubChem=31703].	2	7.971289e-3	1.000000e+0	1.000000e+0	1.254502e+2	7.971289e-3	1	7.971289e-3	1.000000e+0	1	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	TXNDC17
MSigDB Perturbation	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 13.	3	1.052191e-2	1.000000e+0	1.000000e+0	9.503978e+1	1.052191e-2	1	1.052191e-2	1.000000e+0	3	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	TXNDC17
MSigDB Perturbation	RICKMAN_METASTASIS_DN	Genes down-regulated in metastatic vs non-metastatic HNSCC (head and neck squamous cell carcinoma) samples.	4	1.357986e-2	1.000000e+0	1.000000e+0	7.363844e+1	1.357986e-2	1	1.357986e-2	1.000000e+0	5	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	ACKR6
MSigDB Perturbation	COLDREN_GEFITINIB_RESISTANCE_DN	Genes down-regulated in NSCLC (non-small cell lung carcinoma) cell lines resistant to gefitinib [PubChem=123631] compared to the sensitive ones.	5	2.008113e-2	1.000000e+0	1.000000e+0	4.979799e+1	2.008113e-2	1	2.008113e-2	1.000000e+0	4	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	ACKR6
MSigDB Perturbation	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	Down-regulated genes that vary between HNSCC (head and neck squamous cell carcinoma) groups formed on the basis of their level of pathological differentiation: well vs poorly differentiated tumors.	6	3.083527e-2	1.000000e+0	1.000000e+0	3.243039e+1	3.083527e-2	1	3.083527e-2	1.000000e+0	8	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	TXNDC17
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_UP	Genes up-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	7	3.673544e-2	1.000000e+0	1.000000e+0	2.722167e+1	3.673544e-2	1	3.673544e-2	1.000000e+0	10	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	ACKR6
MSigDB Perturbation	MARTENS_TRETINOIN_RESPONSE_DN	Genes down-regulated in NB4 cells (acute promyelocytic leukemia, APL) in response to tretinoin [PubChem=444795]; based on Chip-seq data.	8	3.772631e-2	1.000000e+0	1.000000e+0	2.650670e+1	3.772631e-2	1	3.772631e-2	1.000000e+0	15	8.449668e-2	1.000000e+0	1.000000e+0	1.157959e+1	8.635885e-2	1	779	5.000000e-1	1.283697e-3	unnamed	TXNDC17
MSigDB Perturbation	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	Genes down-regulated in prefrontal cortex (PFC) of mice carrying a hemizygotic microdeletion in the 22q11.2 region.	9	3.826834e-2	1.000000e+0	1.000000e+0	2.613126e+1	3.826834e-2	1	3.826834e-2	1.000000e+0	13	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	TXNDC17
MSigDB Perturbation	HORIUCHI_WTAP_TARGETS_UP	Genes up-regulated in primary endothelial cells (HUVEC) after knockdown of WTAP [GeneID=9589] by RNAi.	10	3.931200e-2	1.000000e+0	1.000000e+0	2.543752e+1	3.931200e-2	1	3.931200e-2	1.000000e+0	6	3.145511e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	286	5.000000e-1	3.496503e-3	unnamed	ACKR6
MSigDB Perturbation	KUMAR_TARGETS_OF_MLL_AF9_FUSION	Myeloid leukemia model in mice with germ-line MLL-AF9 fusion knock-in [GeneID=4297;4300]: genes changed in comparison among the leukemic, preleukemic and wild-type animals.	11	4.113256e-2	1.000000e+0	1.000000e+0	2.431164e+1	4.113256e-2	1	4.113256e-2	1.000000e+0	9	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	TXNDC17
MSigDB Perturbation	MIKKELSEN_NPC_HCP_WITH_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing histone H3 trimethylation mark at K27 (H3K27me3) in neural progenitor cells (NPC).	12	4.542935e-2	1.000000e+0	1.000000e+0	2.201220e+1	4.542935e-2	1	4.542935e-2	1.000000e+0	7	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	ACKR6
MSigDB Perturbation	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	Genes down-regulated in HEK-293 cells (fibroblast) upon knockdown of CTBP1 but not of SATB1 [GeneID=1487, 6304] by RNAi.	13	4.677513e-2	1.000000e+0	1.000000e+0	2.137888e+1	4.677513e-2	1	4.677513e-2	1.000000e+0	11	4.677771e-2	1.000000e+0	1.000000e+0	2.112529e+1	4.733662e-2	1	427	5.000000e-1	2.341920e-3	unnamed	TXNDC17
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3K4ME2	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation mark at K4 (H3K4me2) in neural precursor cells (NPC).	14	5.352102e-2	1.000000e+0	1.000000e+0	1.868425e+1	5.352102e-2	1	5.352102e-2	1.000000e+0	12	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	ACKR6
MSigDB Perturbation	LOPEZ_MBD_TARGETS	Genes up-regulated in HeLa cells (cervical cancer) after simultaneus knockdown of all three MBD (methyl-CpG binding domain) proteins MeCP2, MBD1 and MBD2 [GeneID=4204;4152;8932] by RNAi.	15	6.397820e-2	1.000000e+0	1.000000e+0	1.563032e+1	6.397820e-2	1	6.397820e-2	1.000000e+0	17	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	TXNDC17
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	16	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	16	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	TXNDC17
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	17	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	18	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	TXNDC17
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	The 'group 3 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	18	7.827498e-2	1.000000e+0	1.000000e+0	1.277547e+1	7.827498e-2	1	7.827498e-2	1.000000e+0	14	7.321825e-2	1.000000e+0	1.000000e+0	1.340342e+1	7.460784e-2	1	673	5.000000e-1	1.485884e-3	unnamed	ACKR6
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	19	1.332338e-1	1.000000e+0	1.000000e+0	7.505605e+0	1.332338e-1	1	1.332338e-1	1.000000e+0	19	1.575486e-1	1.000000e+0	1.000000e+0	6.086707e+0	1.642924e-1	1	1482	5.000000e-1	6.747638e-4	unnamed	ACKR6
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	20	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	20	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	TXNDC17
MSigDB Predicted Promoter Motifs	V$CP2_02	Motif GCTGGNTNGNNCYNG matches TFCP2: transcription factor CP2	1	2.833857e-2	1.000000e+0	1.000000e+0	3.528760e+1	2.833857e-2	1	2.833857e-2	1.000000e+0	1	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	TXNDC17
MSigDB Predicted Promoter Motifs	RYTTCCTG_V$ETS2_B	Motif RYTTCCTG matches ETS2: v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)	2	1.058331e-1	1.000000e+0	1.000000e+0	9.448844e+0	1.058331e-1	1	1.058331e-1	1.000000e+0	2	1.122862e-1	1.000000e+0	1.000000e+0	8.648610e+0	1.156255e-1	1	1043	5.000000e-1	9.587728e-4	unnamed	TXNDC17
InterPro	IPR010357	Protein of unknown function DUF953, thioredoxin-like	1	2.805075e-5	2.642942e-1	2.642942e-1	3.564967e+4	2.805075e-5	1	2.805075e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TXNDC17
InterPro	IPR001666	Phosphatidylinositol transfer protein	2	6.187340e-4	1.000000e+0	1.000000e+0	1.616203e+3	6.187340e-4	1	6.187340e-4	1.000000e+0	2	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	ACKR6
InterPro	IPR013209	LNS2, Lipin/Ned1/Smp2	3	6.597314e-4	1.000000e+0	1.000000e+0	1.515768e+3	6.597314e-4	1	6.597314e-4	1.000000e+0	2	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	ACKR6
InterPro	IPR004177	DDHD	4	7.378725e-4	1.000000e+0	1.000000e+0	1.355248e+3	7.378725e-4	1	7.378725e-4	1.000000e+0	2	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	ACKR6
InterPro	IPR023214	HAD-like domain	5	7.761995e-3	1.000000e+0	1.000000e+0	1.288329e+2	7.761995e-3	1	7.761995e-3	1.000000e+0	5	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	ACKR6
InterPro	IPR012336	Thioredoxin-like fold	6	9.333784e-3	1.000000e+0	1.000000e+0	1.071377e+2	9.333784e-3	1	9.333784e-3	1.000000e+0	6	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	TXNDC17
TreeFam	TF313854	TXNDC17	1	2.805075e-5	2.279404e-1	2.279404e-1	3.564967e+4	2.805075e-5	1	2.805075e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TXNDC17
TreeFam	TF312967	ACKR6, PITPNM1, PITPNM2	2	1.575809e-4	1.000000e+0	6.402512e-1	6.345946e+3	1.575809e-4	1	1.575809e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	ACKR6
HGNC Gene Families	ACKR	ACKR	1	2.061769e-4	9.855256e-2	9.855256e-2	4.850205e+3	2.061769e-4	1	2.061769e-4	1.000000e+0	1	4.433975e-4	2.119440e-1	2.119440e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	ACKR6
Ensembl Genes	7816	TXNDC17	1	2.805075e-5	5.060636e-1	5.060636e-1	3.564967e+4	2.805075e-5	1	2.805075e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TXNDC17
Ensembl Genes	7814	ACKR6	2	6.651303e-5	1.000000e+0	5.999808e-1	1.503465e+4	6.651303e-5	1	6.651303e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	1	1.018445e-2	1.000000e+0	1.000000e+0	9.818892e+1	1.018445e-2	1	1.018445e-2	1.000000e+0	13	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	2	1.315757e-2	1.000000e+0	1.000000e+0	7.600189e+1	1.315757e-2	1	1.315757e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB1 [GeneID=7040] versus those treated with TGFB3 [GeneID=7043] and IL6 [GeneID=3569].	3	1.423036e-2	1.000000e+0	1.000000e+0	7.027231e+1	1.423036e-2	1	1.423036e-2	1.000000e+0	3	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 T cells at the peak expansion phase (day8) versus those at contraction (day 15) after LCMV-Armstrong infection.	4	1.439294e-2	1.000000e+0	1.000000e+0	6.947850e+1	1.439294e-2	1	1.439294e-2	1.000000e+0	34	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	5	1.441184e-2	1.000000e+0	1.000000e+0	6.938738e+1	1.441184e-2	1	1.441184e-2	1.000000e+0	17	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE339_CD8POS_VS_CD4CD8DN_DC_UP	Genes up-regulated in comparison of CD8 dendritic cells (DC) versus CD4- [GeneID=920] CD8- DCs.	6	1.519949e-2	1.000000e+0	1.000000e+0	6.579170e+1	1.519949e-2	1	1.519949e-2	1.000000e+0	25	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h.	7	1.604819e-2	1.000000e+0	1.000000e+0	6.231232e+1	1.604819e-2	1	1.604819e-2	1.000000e+0	17	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of naive versus memory CD8 T cells (day 40+ following LCMV-Armstrong infection).	8	1.646202e-2	1.000000e+0	1.000000e+0	6.074588e+1	1.646202e-2	1	1.646202e-2	1.000000e+0	31	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN	Genes down-regulated in comparison of T effector cells from uninfected mice versus T effector cells from mice infected with S. mansoni.	9	1.656474e-2	1.000000e+0	1.000000e+0	6.036919e+1	1.656474e-2	1	1.656474e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD8POS_DC_DN	Genes down-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD8 DCs.	10	1.677105e-2	1.000000e+0	1.000000e+0	5.962656e+1	1.677105e-2	1	1.677105e-2	1.000000e+0	31	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.	11	1.705692e-2	1.000000e+0	1.000000e+0	5.862724e+1	1.705692e-2	1	1.705692e-2	1.000000e+0	3	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	12	1.707246e-2	1.000000e+0	1.000000e+0	5.857388e+1	1.707246e-2	1	1.707246e-2	1.000000e+0	17	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP	Genes up-regulated in comparison of Th1 cells versus naive CD4 [GeneID=920] T cells.	13	1.713505e-2	1.000000e+0	1.000000e+0	5.835993e+1	1.713505e-2	1	1.713505e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP	Genes up-regulated in comparison of naive B cell versus pre-germinal tonsil B cells.	14	1.713612e-2	1.000000e+0	1.000000e+0	5.835627e+1	1.713612e-2	1	1.713612e-2	1.000000e+0	5	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h.	15	1.733399e-2	1.000000e+0	1.000000e+0	5.769012e+1	1.733399e-2	1	1.733399e-2	1.000000e+0	25	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE27786_NKTCELL_VS_ERYTHROBLAST_UP	Genes up-regulated in comparison of NKT cells versus erythroblasts.	16	1.769173e-2	1.000000e+0	1.000000e+0	5.652360e+1	1.769173e-2	1	1.769173e-2	1.000000e+0	2	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h.	17	1.779648e-2	1.000000e+0	1.000000e+0	5.619089e+1	1.779648e-2	1	1.779648e-2	1.000000e+0	28	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 8 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 8 h.	18	1.802675e-2	1.000000e+0	1.000000e+0	5.547312e+1	1.802675e-2	1	1.802675e-2	1.000000e+0	22	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN	Genes down-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	19	1.831053e-2	1.000000e+0	1.000000e+0	5.461338e+1	1.831053e-2	1	1.831053e-2	1.000000e+0	1	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 8 h.	20	1.839724e-2	1.000000e+0	1.000000e+0	5.435599e+1	1.839724e-2	1	1.839724e-2	1.000000e+0	25	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_MAST_CELL_UP	Genes up-regulated in comparison of eosinophils versus mast cells.	21	1.842396e-2	1.000000e+0	1.000000e+0	5.427716e+1	1.842396e-2	1	1.842396e-2	1.000000e+0	13	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	22	1.877213e-2	1.000000e+0	1.000000e+0	5.327045e+1	1.877213e-2	1	1.877213e-2	1.000000e+0	28	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP	Genes up-regulated in comparsion of ActCD8 versus ActCD8TGF (see Fig. 1 in the paper for details).	23	1.878186e-2	1.000000e+0	1.000000e+0	5.324285e+1	1.878186e-2	1	1.878186e-2	1.000000e+0	24	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN	Genes down-regulated in comparison of untreated CD8+ dendritic cells (DC) at 4 h versus those treated with IFNG [GeneID=3458] at 4 h.	24	1.917767e-2	1.000000e+0	1.000000e+0	5.214399e+1	1.917767e-2	1	1.917767e-2	1.000000e+0	28	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN	Genes down-regulated in comparison of control CD4 [GeneID=920] CD8 thymocytes versus those after stimulation with anti-Valpha2 antibodies.	25	1.923267e-2	1.000000e+0	1.000000e+0	5.199487e+1	1.923267e-2	1	1.923267e-2	1.000000e+0	33	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_NKCELL_DN	Genes down-regulated in comparison of B cells versus NK cells.	26	1.937323e-2	1.000000e+0	1.000000e+0	5.161761e+1	1.937323e-2	1	1.937323e-2	1.000000e+0	22	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 16 h.	27	1.943857e-2	1.000000e+0	1.000000e+0	5.144411e+1	1.943857e-2	1	1.943857e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_TH2_UP	Genes up-regulated in comparison of eosinophils versus Th2 cells.	28	1.960204e-2	1.000000e+0	1.000000e+0	5.101511e+1	1.960204e-2	1	1.960204e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_TH1_UP	Genes up-regulated in comparison of eosinophils versus Th1 cells.	29	2.005436e-2	1.000000e+0	1.000000e+0	4.986447e+1	2.005436e-2	1	2.005436e-2	1.000000e+0	17	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_NKCELL_UP	Genes up-regulated in comparison of basophils versus NK cells.	30	2.006982e-2	1.000000e+0	1.000000e+0	4.982605e+1	2.006982e-2	1	2.006982e-2	1.000000e+0	36	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	Genes up-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.	31	2.098226e-2	1.000000e+0	1.000000e+0	4.765931e+1	2.098226e-2	1	2.098226e-2	1.000000e+0	12	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN	Genes down-regulated in comparison of follicular B cells versus late germinal center (GC) B cells.	32	2.199600e-2	1.000000e+0	1.000000e+0	4.546281e+1	2.199600e-2	1	2.199600e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN	Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.	33	2.242666e-2	1.000000e+0	1.000000e+0	4.458979e+1	2.242666e-2	1	2.242666e-2	1.000000e+0	17	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TXNDC17
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_NKCELL_DN	Genes down-regulated in comparison of B cells versus NK cells.	34	2.313552e-2	1.000000e+0	1.000000e+0	4.322358e+1	2.313552e-2	1	2.313552e-2	1.000000e+0	5	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	35	2.316487e-2	1.000000e+0	1.000000e+0	4.316882e+1	2.316487e-2	1	2.316487e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	ACKR6
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_BCELL_UP	Genes up-regulated in comparison of eosinophils versus B cells.	36	2.468384e-2	1.000000e+0	1.000000e+0	4.051234e+1	2.468384e-2	1	2.468384e-2	1.000000e+0	35	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	ACKR6
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
